The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.

Orem A, Cimşit G, Değer O, Orem C, Vanizor B

Open source

DOI
10.1016/s0009-8981(99)00062-5
Published
1999 Jun 15
Container
Clinica chimica acta; international journal of clinical chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0009-8981-99-00062-5,
  title = {The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.},
  author = {Orem A and Cimşit G and Değer O and Orem C and Vanizor B},
  year = {1999},
  journal = {Clinica chimica acta; international journal of clinical chemistry},
  doi = {10.1016/s0009-8981(99)00062-5},
  url = {https://doi.org/10.1016/s0009-8981(99)00062-5}
}

RIS

TY  - JOUR
TI  - The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.
AU  - Orem A
AU  - Cimşit G
AU  - Değer O
AU  - Orem C
AU  - Vanizor B
PY  - 1999
JO  - Clinica chimica acta; international journal of clinical chemistry
DO  - 10.1016/s0009-8981(99)00062-5
UR  - https://doi.org/10.1016/s0009-8981(99)00062-5
ER  - 

APA

A, O., G, C., O, D., C, O., & B, V. (1999). The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasis.. Clinica chimica acta; international journal of clinical chemistry. https://doi.org/10.1016/s0009-8981(99)00062-5

Source records